Beauty Company Hit With Derivative Suit Over Skin Tech Woes
Directors and officers at the Beauty Health Co. hid bad news about a defective skin care device for 18 months, leading to stock price drops, analyst downgrades and a securities class...To view the full article, register now.
Already a subscriber? Click here to view full article